Comparison of Nifedipine and Nisoldipine on Human Arteries and Human Cardiac Tissues In Vitro
Studies were carried out on the action of nifedipine and nisoldipine on the contractile activity of human, isolated, coronary and mammary arteries and human, isolated, auricular and ventricular muscles. Nisoldipine depressed in a dose dependent manner the spontaneous rhythmic contractions displayed by the coronary artery preparations and at 1 nM abolished these contractions. Nisoldipine was twenty times more potent than nifedipine as an inhibitor of increase in tone induced by depolarization (100 mM K+). The rhythmic activity induced by serotonin (10μM) was more sensitive to nisoldipine than to nifedipine.
Nifedipine was five times (ventricular muscles) and ten times (auricular muscles) more potent than nisoldipine as negative inotropic agent.
From such observations in human isolated tissues, it appears that nisoldipine has a higher vascular selectivity than nifedipine. This indicates potential differences in the clinical use of these dihydropyridines.
KeywordsContractile Activity Human Coronary Artery Ventricular Muscle Calcium Entry Blocker Cardiac Preparation
Unable to display preview. Download preview PDF.
- 6.Godfraind T, Miller RC (1983a) Pharmacology of coronary arteries. In: De Bakey ME, Gotto AM (eds) Factors influencing the course of myocardial ischemia. Elsevier/North Holland, Amsterdam, pp100–116Google Scholar
- 12.Kazda S, Garthoff B, Meyer H, Schlobmann K, Stoepel K, Towart R, Vater W, Wehinger E (1980) Pharmacology of a new calcium antagonistic compound, isobutylmethyl 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylate (nisoldipine, Bay k 5552). Arzneimittelforsch 30 [II]: 2144–2162PubMedGoogle Scholar
- 13.Maseri A (1983) The role of coronary artery spasm in ischemic heart disease: implications for treatment and prognosis. In: De Bakey ME, Gotto AM (eds) Factors influencing the course of myocardial ischemia. Elsevier/North Holland, Amsterdam, pp229–238Google Scholar
- 15.Van Nueten JM (1978) Vasodilatation or inhibition of vasoconstriction. In: Vanhoutte PM, Leusen I (eds) Mechanism of vasodilatation. Karger, Basel, pp137–43Google Scholar